AVO vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

AVO

59.8
AI Score
VS
AVO Wins

LUNG

32.9
AI Score

Investment Advisor Scores

AVO

60score
Recommendation
HOLD

LUNG

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AVO LUNG Winner
Revenue 1.02B 66.18M AVO
Net Income -14.40M -32.13M AVO
Gross Margin 9.5% 77.3% LUNG
Net Margin -1.4% -48.5% AVO
Operating Income -4.00M -29.50M AVO
ROE -1.9% -93.9% AVO
ROA -0.9% -29.2% AVO
Total Assets 1.61B 110.21M AVO
Cash 47.10M 52.69M LUNG
Debt/Equity 0.52 1.11 AVO
Current Ratio 1.92 4.05 LUNG
Free Cash Flow -57.90M -18.51M LUNG

Relative Price Performance (Last 90 Days)

AVO 1M: -0.3% · 3M: -9.6% LUNG 1M: +69.3% · 3M: +38.0%

Current Technical Phase

AVO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.4 · Price: $11.78

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.6% over 20 days), RSI 66

RSI (14): 65.9 · Price: $2.98

Fundamentals Snapshot

Metric AVO LUNG
Market Cap — —
Forward P/E 14.8 -3.3
Trailing P/E 395.0 —
Revenue (TTM) — —
Revenue Growth 0.3% 0.1%
Gross Margin 0.1% 0.8%
Operating Margin 0.0% -0.3%
EPS 0.03 -1.01
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AVO is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.